West Pharmaceutical Services Inc
Open
SectorHealthcare
328.47 0.16
Overview
Share price change
24h
Min
325.35
Max
329.03
Income | 6.7M 139M |
|---|---|
Sales | 40M 845M |
P/E Sector Avg | 42.017 49.052 |
EPS | 2.13 |
Dividend yield | 0.27 |
Profit margin | 16.428 |
Employees | 10,800 |
EBITDA | -36M 174M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +13.44% upside |
Dividend yield Sector Avg | 0.27% 2.36% |
|---|---|
Next Earnings | 23 lip 2026 |
Next Dividend date | 5 sie 2026 |
Next Ex Dividend date | 29 lip 2026 |
Market Cap | 2.6B 23B |
|---|---|
Previous open | 328.31 |
Previous close | 328.47 |
News Sentiment
By Acuity
50%
50%
146 / 342 Ranking in Healthcare
West Pharmaceutical Services Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.